Eastern Connecticut Hematology and Oncology is a clinical research site located in Norwich, Connecticut, United States 06360.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Eastern Connecticut Hematology and Oncology has participated in 7 clinical trials with 3 currently active.
Therapeutic areas: SARS-CoV-2 Infection, Solid Tumor, Breast Tumor.
Sponsors: MediMergent, LLC, Tempus AI, Aadi Bioscience, Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Eastern Connecticut Hematology and Oncology has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Eastern Connecticut Hematology and Oncology has 7 clinical trials on record, with 3 currently active. Their work covers SARS-CoV-2 Infection, Solid Tumor, Breast Tumor.
Yes — Eastern Connecticut Hematology and Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.